In an amicus brief filed with the United States Court of Appeals for the Federal Circuit regarding the ACLU-Myriad gene patenting case, James Watson argues that genes should not be patented. (Duke University's Center for Public Genomics has posted the brief here.) Watson writes that genes are a product of nature and encode "vital information" that directs whether a person is male or female, or blonde or brunette.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Defending Open Access

This Week in PNAS

This Week in PLOS

The Missing Drugs

Natural Knockouts

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.